Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

C Koenecke*, D Heim, A van Biezen, M Heuser, M Aljurf, S Kyrcz-Krzemien, L Volin, C A de Souza, T Gedde-Dahl, H Sengeloev, U Schanz, M Komarnicki, C H Arroyo, E Tholouli, E Gluckman, A Esquirol, I Yakoub-Agha, G Gürman, E Olavarria, N Kröger

*Corresponding author for this work
Original languageEnglish
JournalBone Marrow Transplantation
Issue number9
Pages (from-to)1259-61
Number of pages3
Publication statusPublished - Sept 2016


  • Adolescent
  • Adult
  • Algorithms
  • Child
  • Decision Making
  • Female
  • Hematopoietic Stem Cell Transplantation/trends
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis
  • Male
  • Middle Aged
  • Molecular Targeted Therapy/methods
  • Risk Assessment
  • Transplantation, Homologous
  • Treatment Outcome
  • Young Adult

Cite this